- $326.70m
- $305.63m
- $82.03m
Annual income statement for Paysign, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 29.5 | 38 | 47.3 | 58.4 | 82 |
| Cost of Revenue | |||||
| Gross Profit | 14.7 | 21 | 24.1 | 32.2 | 48.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 32.2 | 37.7 | 47.4 | 57.4 | 74.7 |
| Operating Profit | -2.74 | 0.344 | -0.167 | 1.02 | 7.36 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.71 | 1.14 | 2.36 | 4.14 | 10 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.72 | 1.03 | 6.46 | 3.82 | 7.55 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.72 | 1.03 | 6.46 | 3.82 | 7.55 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.72 | 1.03 | 6.46 | 3.82 | 7.55 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.053 | 0.019 | 0.119 | 0.069 | 0.127 |